These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 12113240)

  • 1. Aromatase inhibitors in breast cancer therapy.
    Brueggemeier RW
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):181-91. PubMed ID: 12113240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aromatase inhibitors: new endocrine treatment of breast cancer.
    Brueggemeier RW
    Semin Reprod Med; 2004 Feb; 22(1):31-43. PubMed ID: 15083379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aromatase, aromatase inhibitors, and breast cancer.
    Brueggemeier RW
    Am J Ther; 2001; 8(5):333-44. PubMed ID: 11550075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatase inhibitors in the treatment of breast cancer.
    Brueggemeier RW; Hackett JC; Diaz-Cruz ES
    Endocr Rev; 2005 May; 26(3):331-45. PubMed ID: 15814851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer.
    Berry J
    Clin Ther; 2005 Nov; 27(11):1671-84. PubMed ID: 16368441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Action and Clinical Relevance of Aromatase Inhibitors.
    Murphy MJ
    Oncologist; 1998; 3(2):129-130. PubMed ID: 10388095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase inhibitors and breast cancer.
    Brodie AM; Njar VC
    Semin Oncol; 1996 Aug; 23(4 Suppl 9):10-20. PubMed ID: 8824460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use of aromatase inhibitors in the treatment of advanced breast cancer.
    Trunet PF; Vreeland F; Royce C; Chaudri HA; Cooper J; Bhatnagar AS
    J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):241-5. PubMed ID: 9365196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives.
    Santen RJ
    Breast Cancer Res Treat; 1986; 7 Suppl():S23-35. PubMed ID: 3527304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the use of aromatase inhibitors in breast cancer.
    Brueggemeier RW
    Expert Opin Pharmacother; 2006 Oct; 7(14):1919-30. PubMed ID: 17020418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical differences among the aromatase inhibitors.
    Ligibel JA; Winer EP
    Clin Cancer Res; 2003 Jan; 9(1 Pt 2):473S-9S. PubMed ID: 12538503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of aromatase inhibitors in the treatment of breast cancer.
    Harvey HA
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):32-5. PubMed ID: 9556789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of aromatase inhibitors as adjuvant therapy for early breast cancer in postmenopausal women.
    Mouridsen HT; Robert NJ
    Eur J Cancer; 2005 Aug; 41(12):1678-89. PubMed ID: 16098456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatase inhibitors as potential cancer chemopreventives.
    Kelloff GJ; Lubet RA; Lieberman R; Eisenhauer K; Steele VE; Crowell JA; Hawk ET; Boone CW; Sigman CC
    Cancer Epidemiol Biomarkers Prev; 1998 Jan; 7(1):65-78. PubMed ID: 9456245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focus on anastrozole and breast cancer.
    Mokbel K
    Curr Med Res Opin; 2003; 19(8):683-8. PubMed ID: 14687437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of third-generation aromatase inhibitors and tamoxifen in the adjuvant treatment of postmenopausal patients with hormone-dependent breast cancer: evidence based review.
    Poole R; Paridaens R
    Curr Opin Oncol; 2007 Nov; 19(6):564-72. PubMed ID: 17906453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current status and prospectives of aromatase inhibitors in the treatment of advanced breast cancer].
    Boccardo F
    Minerva Ginecol; 1998 Mar; 50(3):51-63. PubMed ID: 9595916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aromatase inhibitors and breast cancer.
    Miller WR
    Minerva Endocrinol; 2006 Mar; 31(1):27-46. PubMed ID: 16498362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of hormone receptor status on the clinical efficacy of the new-generation aromatase inhibitors: a review of data from first-line metastatic disease trials in postmenopausal women.
    Buzdar AU; Vergote I; Sainsbury R
    Breast J; 2004; 10(3):211-7. PubMed ID: 15125747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are all aromatase inhibitors the same? A review of the current evidence.
    Jänicke F
    Breast; 2004 Dec; 13 Suppl 1():S10-8. PubMed ID: 15585378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.